Last reviewed · How we verify
NCT05054634: COUNTHY
Psycho-oncological Intervention Through Counselling in Patients With Differentiated Thyroid Cancer in Treatment With Radioiodine
trial testing Psycho-oncological Intervention Based on Counselling (PIBC) in Thyroid Cancer in 75 participants. Completed in 31 March 2015.
30 September 2014
Quick facts
| Lead sponsor | Quironsalud |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 75 |
| Start date | 1 June 2013 |
| Primary completion | 30 September 2014 |
| Estimated completion | 31 March 2015 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- Psycho-oncological Intervention Based on Counselling (PIBC)
Conditions studied
- Thyroid Cancer — all drugs for Thyroid Cancer →
Sponsor
Quironsalud
Who can join
18 and older, any sex, with Thyroid Cancer. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Diagnosis and treatment of differentiated thyroid carcinomas cause anxiety and depression. Additionally, these patients suffer hormonal alterations, associated with psychological symptoms (changes in mood, emotional instability, memory loss, etc.). This study aims to evaluate the effectiveness of a psycho-oncological intervention based on Counselling to reduce anxiety and depression related with the treatment in patients with differentiated thyroid carcinomas.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Psycho-Oncological Intervention Through Counseling in Patients With Differentiated Thyroid Cancer in Treatment With Radioiodine (COUNTHY, NCT05054634): A Non-randomized Controlled Study.
Javaloyes N, Crespo A, Redal MC, Brugarolas A, et al · · 2022 · cited 10× · PMID 35282223 · DOI 10.3389/fpsyg.2022.767093
Verify or expand the search:
- PubMed search for NCT05054634
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Thyroid Cancer
Currently open trials in the same condition.
- NCT07428057 — Postoperative Hypocalcemia After Thyroidectomy · recruiting
- NCT07370675 — Active Surveillance for Bethesda IV Thyroid Nodules · NA · recruiting
- NCT07389512 — Pharmaceutical Management in Targeted Radioligand Therapy · recruiting
- NCT07438847 — 177Lu-CTR-FAPI for the Treatment of Thyroid Cancer · Phase 1 · recruiting
- NCT07419932 — Response to Neoadjuvant Treatment in Locally Advanced Thyroid Cancer · recruiting
Other Quironsalud trials
Trials by the same sponsor.
- NCT05861245 — Hypofractionated Protontherapy in Chordomas and Chondrosarcomas of the Skull Base · NA · recruiting
- NCT05171153 — Analysis of Bone Quality in Adult Patients With Inflammatory Bowel Disease · completed
- NCT04438785 — Effects of Myofunctional Therapy With an Application in Severe Apnea/Hypopnea Sleep Obstructive Syndrome (MTASSAOS) · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05054634 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Quironsalud
- Last refreshed: 23 September 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05054634.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing